Who backs Abcuro?
20 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| New Enterprise Associates | Venture capital |
| BlackRock | Other |
| Foresite Capital | Venture capital |
| Samsara BioCapital | Venture capital |
| ShangBay Capital | — |
| Redmile Group | PE / buyout |
| Bain Capital Life Sciences | Venture capital |
| Soleus Capital | PE / buyout |
| New Leaf Venture | Venture capital |
| + 10 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Abcuro investors
20 investors are on record for Abcuro, including RA Capital Management, New Enterprise Associates, BlackRock and Foresite Capital. By type, the record holds 5 venture capital firms, 2 private equity firms and 1 asset manager. The Series C in Feb 2025 drew 13 investors.
Free account
More of Abcuro with a free account
- ·The complete investor list: 20 names
- ·Watch Abcuro: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 20 firms already write checks for companies like Abcuro in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View